Related News

UCSF Enters Drug Discovery Agreement with Genentech
February 18, 2010 -- The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug ... 
19 Feb 2010
Business News, Research News
Stem Cells and Genomics: The hottest topics in 2009
From The Scientist, here's a list of the 5 most-cited papers in 2009 - developed from data compiled by ScienceWatch. ... 
17 Feb 2010
Research News
Neurologix Gene Therapy for Parkinson's Disease Phase II Trial Results in 2010
Summary Neurologix, Inc.   initiated the 44 patient Phase II trial in December 2008, and completed the surgical portion of their multi-center, controlled, double-blinded assessment of ... 
15 Feb 2010
Clinical Trial News
Direct conversion of fibroblasts to functional neurons - iN cells
This week in Nature, Marius Wernig and colleagues demonstrate expression of three factors, Ascl1, Brn2, and Myt1l, can convert fibroblasts to functional neurons in vitro (iN cells), bypassing the ... 
27 Jan 2010
Research News
Responses: 2
NIH contract calls for Coriell to include iPS cells in genetic biobank
Philadelphia Business Journal - The Coriell Institute for Medical Research received a five-year, $27 million contract Monday from the National Institutes of Health for a human genetic biobank and new ... 
26 Jan 2010
Business News
Neurologix Gains Broadened U.S. Patent Protection for Its GAD-Based Gene Delivery System
FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, ... 
26 Jan 2010
Business News
MedGenesis Announces Agreements With Amgen and Biovail to develop GDNF therapy for Parkinson's
Victoria, British Columbia, (January 12, 2010): MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with ... 
12 Jan 2010
Business News
Parkinson's Disease Society Announces 2010 Innovation Grants
The Parkinson's Disease Society (PDS) invests in bold new ideas that have the potential to transform the lives of people with Parkinson's. Innovation grants support exceptionally innovative research ... 
07 Jan 2010
Funding News
Responses: 1
Request for Information: Soliciting Input on Huntington’s Disease Best Practice Guidelines for Therapeutic Target Validation
This is a time-sensitive Request for Information (RFI) issued by the National Institute of Neurological Disorders and Stroke. The purpose of this RFI is to solicit recommendations on the best ... 
05 Jan 2010
Funding News, Government News
The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinson's Disease Treatments
NEW YORK, November 30, 2009 — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced $1.5 million in total awards to six research teams working to develop ... 
30 Nov 2009
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes